Session 7 - pharmacokinetics Flashcards
- Understand the importance of Pharmacokinetics applied to clinical practice
- Used the Interactive Clinical Pharmacology website icp.nz
- Recognise main routes of drug administration into the body
- Understand factors affecting drug Absorption and Distribution
- Recognise Equations used for Bioavailability and Volume of Distribution
- Understand factors affecting drug Metabolism and Excretion
- Recognise equations used for Clearance and drug Half Life
- Understand difference between Linear and Non-Linear Kinetics
What is Pharmacokinetics
What the body does to drugs:
- Absorption (drug in)
- Distribution (drug in)
- Metabolism (drug out)
- Elimination (drug out)
Recognise main routes of drug administration into the body LO
Enteral: Delivery into internal environment of body - GI Tract
Parenteral: Delivery via all other routes that are not the GI

Understand factors affecting drug Absorption and Distribution LO
Drug Absorption
- Oral route - majority of formulations most convenient
- Normally little absorption in stomach - SA = 0.75 - 1m2
- Drug mixes with chyme enters small intestine
- Small intestine = 6-7 m in length x 2.5 cm diameter
- Total SA for absorption = 30-35 m2
- Constant GI movement - mixing - presenting drug molecules to GI epithelia
Drug Absorption Small Intestine
Typical Transit Time = ?
Varying motility = ?
Weakly acidic pH = ?
3-5 hrs
1-10 hrs
6 -7 pH
- Molecular Level how do drugs pass the plasma membrane in the SI
- Passive Diffusion
- Facilitated Diffusion
- Primary / Secondary Active Transport
- Pinocytosis
- Passive Diffusion
Passive Diffusion 1
- Common mechanism for lipophilic drugs weak acids/ bases
- Lipophilic drugs e.g. steroids diffuse directly down concentration gradient into GI capillaries
Passive Diffusion 2
- Weak acids/bases protonated /deprotonated species can diffuse
- * E.g. Valproate : Anti -Epileptic Drug weak acid pKa = 5
- In gut at pH 6 - 10 % Valproate protonated - Lipophilic
- Lipophilic species crosses GI epithelia
- Over transit time 4-5 hrs and very large GI SA valproate diffuses into GI capillary bed
Drug Absorption: Facilitated Diffusion: Solute Carrier (SLC) Transport
- Molecules (or Solutes) with nett ionic + or - charge within GI pH range can be carried across GI epithelia
- Passive process based on electrochemical gradient for that (solute) molecule SLCs are either OATs and OCTs
- Large family – expressed in all body tissue
- Pharmacokinetically important for drug absorption and elimination
- Highly expressed in GI, Hepatic and Renal Epithelia
Secondary Active: Solute Carrier (SLC) Transport
- SLCs can also enable drug transport in GI by Secondary Active Transport
- Not utilise ATP - Transport driven by pre-existing electrochemical gradient across GI epithelial membrane e.g. Renal OATs and OCTs
Example
- Fluoxetine/Prozac - SSRI antidepressant co-transported with Na+ ion
- B-lactam antibiotics/Penicillin - co-transported with H+ ion
Understand factors affecting drug Absorption and Distribution LO
- Physicochemical Factors:
- GI Physiology:
- First Pass Metabolism by GI and Liver:
- • GI length /SA
- Drug lipophilicity / pKa
- Density of SLC expression in GI
- • Blood Flow: Increase post meal – drastically reduce shock/anxiety exercise
- GI Motility: Slow post meal - rapid with severe diarrhoea
- Food /pH: Food can reduce/increase uptake. Low pH destroy some drugs
- • Gut Lumen: Gut/Bacterial Enzymes - can denature some drugs
• Gut Wall/Liver (larger expression) : Some drugs metabolised by two major enzyme groups Cytochrome P450s:
- Phase I Enzymes Conjugating
- Phase II Enzymes
‘First Pass’ metabolism:
Reduces availability of drug reaching systemic circulation - therefore affects therapeutic potential
Recognise Equations used for Bioavailability and Volume of Distribution LO
Drug Absorption: Bioavailability
- Bioavailability Definition:
- What is most common reference compartment
- How do you work out bioavailability?
- Fraction of a defined dose which reaches its way into a specific body compartment
- Cvs/circulatory
- IV bolus = 100%
- No physical/metabolic barriers to overcome
- For other routes - compare amount reaching CVS by other route referenced to intravenous bioavailability
- Most common comparison oral or (O)/(IV)
How do you work out Oral Bioavailability (F)?

What is the first stage of drug distrubution?
First stage
- Bulk flow - Large distance via arteries to capillaries
- Diffusion - Capillaries to interstitial fluid to cell membranes to targets
- Barriers to Diffusion - Interactions /local permeability/non- target binding
Understand factors affecting drug Absorption and Distribution LO
- Major factors affecting drug distribution:
Drug Molecule Lipophilicity/Hydrophilicity
- If drug is largely lipophilic can freely move across membrane barriers
- If drug is largely hydrophilic journey across membrane barriers dependent on factors described for Absorption
- Capillary permeability
- Drug pKa & Local pH
- Presence of OATs/OCTs
Degree of drug binding to plasma and/or tissue proteins
• In circulation many drugs bind to proteins e.g.
- Albumin Globulins
- Lipoproteins Acid glycoproteins
What are the differing levels of capillary permeability?
- Enables variation in entry by charged drugs into tissue interstitial fluid
- Then on to target site (s)

Elaborate on why Degree of drug binding to plasma and/or tissue proteins affects distrubution of the drug
- Only free drug molecule can bind to target site(s)
- Binding in plasma/tissue decreases free drug available for binding
- Plasma/Tissue protein bound drug acts as ‘reservoir’
- Binding forces not strong – bound/unbound in equilibrium
- Binding can be up to = 100%
(Aspirin = 50%)
Simplify body fluid compartments in to model with three main compartments




Increasing Penetration by Drug into Interstitial and Intracellular Fluid Compartments Leads to?
- Decreasing Plasma Drug Concentration
- Increasing Vd
Recognise Equations used for Bioavailability and Volume of Distribution LO
- What is Vd?
- Smaller Vd values - ?
- Larger Vd values - ?
- What is the equation for volume of distrubution?
- What is the units for Vd ?
- Summarises movement out of Plasma -> Interstitial -> Intracellular Compartment
- less penetration of Interstitial/Intracellular Fluid Compartment
- less penetration of Interstitial/Intracellular Fluid Compartment
- Look at the image

When can Vd be affected?

Drug Elimination
Elimination
- Term used to cover both Metabolic and Excretory Processes
- Both ‘flow’ processes closely integrated to optimise drug removal
- Elimination removes both exogenous and endogenous molecular species
- Evolutionary advantage in recognising xenobiotics – potential toxins
- Protective and Homeostatic function
Understand factors affecting drug Metabolism and Excretion LO
- Hepatic Drug Metabolism: Phase 1 and II
- Drug Metabolism largely takes place in Liver via ?
- Enzymes expressed ?
- Very large hepatic reserve – also ‘first port of call’ after GI absorption
- Phase I and II Enzymes function and why?
- Phase 1 and II enzymes
throughout body tissues
- • Metabolise drugs - increase ionic charge enhance renal elimination
- Lipophilic drugs diffuse out renal tubules back into plasma
- Once metabolised - drugs usually inactivated *
Drug Metabolism: Phase 1
- Phase 1 Metabolism is carried out by Cytochrome ?
- Phase 1 enzymes collectively refer to as ?
- Large group of > 50 isozymes located on ?
- Catalyse: ?
- CYP450s are versatile generalists, what does that mean?
- What do the CYP450s do?
- What happens to the drugs CYP450s have ?
- * Some ‘pro-drugs’ activated by Phase I metabolism to active species
- P450 Enzymes
- CYP450s
- external face of ER
- redox; dealkylation; hydroxylation reactions
- metabolise very wide range of molecules
- Metabolised drugs have increased ionic charge
- Metabolised drug eliminated directly or go onto Phase II
Drug Metabolism: Phase 1
Phase 1 Metabolism can activate prodrugs
Some ‘pro-drugs’ activated by Phase I metabolism to active species
- Example: ?
- Codeine to Morphine
In metabolisers = 0-15% Codeine metabolised by CYP2D6 to Morphine
Morphine x 200 Codeine affinity for Opioid µ-Receptor
CYP2D6 exhibits genetic polymorphism
Drug Metabolism Phase II
- Phase II Metabolism is carried out by ? Enzymes
- Phase II enzymes - mainly (location) enzymes
- Phase II still generalists but ?
- Enhance hydrophilicity by ?
- Catalyse:
- Phase II metabolised drugs further increased ?
- Phase II metabolism enhances?
- Hepatic
- cytosolic
- exhibit more rapid kinetics than CYP450s
- Further inc ionic charge - add to Phase I
- Sulphation - Glucorinadation - Glutathione conjugation -
Methylation N-acetylation - ionic charge
- renal elimination


Cytochrome P450 Enzymes
Cytochrome P450 enzymes include three superfamilies
- Three superfamilies:
- Isozyme members in each family coded by suffix: e.g. CYP3A4
- Six isozymes metabolise = 90% prescription drugs
- Other isozymes exhibit very variable hepatic expression
- Each isozyme optimally metabolise specific drugs but do show overlap
- CYP 1, 2 and 3
2.
Understand factors affecting drug Metabolism and Excretion LO
- Many Factors of Direct Clinical Relevance:
- CYP450s: Induction and Inhibition and Genetic Factors:
- • Age (Variable patterns in paediatric groups reduced in elderly)
- Sex (gender differences drugs e.g. alcohol metabolism slower in women)
- General Health/Dietary/Disease - especially Hepatic Renal CVS
- • Other drugs (Rx/OTC) can induce or inhibit CYP450s
• Genetic variability/polymorphism/ non-expression affects CYP450s
Phase I Metabolism: CYP450 Induction
- Concurrent administration of certain drugs (including just the one drug) can
induce specific CYP450 isozymes. Induction mechanism via: ? - If another drug in body metabolised by induced CYP450 isozyme then its rate of elimination will be ? Plasma levels of drug will ?
- For patient can have serious therapeutic consequences if levels drop significantly. Induction process typically occurs over ?
- Inc transcription; inc translation; slower degradation
- increased, fall
- 1-2 weeks
Phase I Metabolism: CYP450 Induction
Give an example of CYP450 Induction:
Carbamezepine (CBZ)
- CBZ is an anti-epileptic metabolised by CYP3A4
- CBZ induces CYP3A4 – lowering its own levels affecting control of epilepsy
- CBZ needs careful monitoring in first few month post prescription
Phase I Metabolism: CYP450 Inhibition
CYP450 Inhibition
- Concurrent administration of certain drugs (including just the one drug) can inhibit specific CYP450 isozymes. Inhibition mechanism via: ?
- If another drug in body metabolised by inhibited CYP450 isozyme then its rate of elimination will be ? Plasma levels of drug will then ?
- For patient can have serious side effects consequences if levels rise significantly. Inhibition process occurs within?
- competitive/non-competitive inhibition
- slowed down, increase
- 1 to a few days
Phase I Metabolism: CYP450 Inhibition
Examples of CYP450 Inhibition: ?
- Grapefruit Juice inhibits CYP3A4
- CYP3A4 metabolises Verapimil used to treat high blood pressure (BP)
- Consequence can be much reduced BP and fainting
Phase I Metabolism: Genetic Factors
Genetic Variation
- CYP2C9: Not expressed in:
- CYP2C19: Not expressed in: ?
Prescriptive Practice Review
• Need to consider safety/efficacy if not metabolised /rapidly metabolised
- 1% Caucasians; 1% Africans
• Metabolises NSAIDs, Tolbutamide, Phenytoin
- 5% Caucasians; 30% Asians
• Metabolises Omeprazole, Valium, Phenytoin
Drug Metabolism: Genetic Polymorphism
- Genetic Polymorphism: Codeine and CYP2D6
‘Pro-drugs’ activated by Phase I metabolism to active species
Earlier example: Codeine to Morphine
- CYP2D6 gene highly polymorphic
- CYP2D6 variants categorized into: poor; normal/high; ultrarapid metabolisers
Poor - codeine to morphine - may not experience pain relief
Ultrarapid - codeine to morphine - lead to morphine intoxication/ADRs
Genetic Variation/Polymorphism
- CYP2D6: Not expressed in: ?
- Example of Polymorphism
- Metabolises ?
- CYP2D6: Not expressed in: ?
- 7% Caucasians; Hyperactive 30% East Africans
Codeine, TCAs
Drug Elimination
- Routes of Drug elimination ?
- Main route of drug elimination is kidney
- Other routes: bile; lung; breast milk (deliver to baby); sweat, tears; genital secretions; saliva
- Renal Excretion. Three Processes:
- Glomerular Filtration
- Active tubular secretion
- Passive tubular reabsorption
- Glomerular Filtration
-
Glomerular Filtration
- Glomerulus = ?% renal blood flow
- ? drug enter via Bowman’s capsule -
Proximal Tubular Secretion
- Remaining ?% blood via peritubular capillaries
- High Expression of ? Function?
- Raison d’etre of Phase I and II metabolism
- Facilitated Diffusion/Secondary Active Transport
- Along tubule length water resorbed
- In tubule [Solutes] inc
- Therefore lipophilics pass back into blood
- Henderson-Hasselbach
+ If tubular pH and molecule species pKa favourable
+ Get neutral AH or B species - reabsorbed by blood
- Distal Tubular Reabsorption
Examples:
- OATs: ?
- OCTs: ?
- Transport subject to competition between drugs can effect pharmacokinetics/ therapeutics

- 20
- Unbound
- 20
- 80
- OATs and OCTs & Carry ionised molecules
- 80
- Urate (Gout); Penicillins; NSAIDs; Antivirals
- Morphine; Histamine; Chlorpromazine
- Urate (Gout); Penicillins; NSAIDs; Antivirals
Recognise equations used for Clearance and drug Half Life LO
- What is Clearance?
- Total Drug Clearance consists of that from all routes. For most drugs -
Total Body Clearance = ?
- The rate of Elimination of a drug from the body OR
The Volume of Plasma that is completely cleared of the drug per unit time
- Total Body Clearance = Hepatic Clearance + Renal Clearance
Clearance is formally defined as: The Volume of Plasma that is completely cleared of the drug per unit time
- CL measured in ?
- But this ‘Volume’ is really referenced to ?
- Real Plasma Volume is = ?
Real Volume of Plasma cannot be ‘completely’ cleared of drug via glomerular filtration/ tubular secretion. In model, CL better thought of as ‘Apparent Rate of Elimination’.
- ml/min or ml.min-1
- Vd: the apparent volume of distrubution
- 3 Litres
CL and Vd
- • Along with the concept of Vd clearance predicts how long drug will stay in body
• Clinically Essential for informing:
- In short answers ‘How long is drug in body and doing any therapeutic good? Together CL & Vd provide estimate of ?
- Designing dosing schedule
- Therapeutic regimes levels
- Minimising ADRs
- Designing dosing schedule
- ‘Drug Half-Life’ or t1/2
Drug Half Life
- Defined as?
- • T 1/2 is dependent on Vd & CL
• If CL stays same and Vd increases then t 1/12 also ?
• If CL increases & Vd stays the same then t1/2 ? - How do you work out T1/2
- The amount of time over which the concentration a drug in plasma decreases to one half of that concentration value it had when it was first measured
- increases
decreases
- (Image)




Linear Elimination Kinetics:
Why are they Linear ?
- The rate of Metabolism or Excretion is proportional to Concentration of Drug
- That is if there are
Plenty of Phase I/II enzyme sites
Plenty of OAT/OCT Transporters
• Then the rate of metabolism /transport will be proportional to the number of molecules occupying a catalytic/ carrier site per unit time
Why are they Linear ?
Hypothetical Examples
• Hepatic Phase I CYP450 Metabolism for Pretend Drug o If there are no molecules then the rate is none there is nothing to catalyse/transport
o If the plasma concentration is 50 uM then lets say rate is 10 million molecules/second
o If the plasma concentration is 100 uM then the rate is ?
o If the plasma concentration is 200 uM then the rate is ?
o Equally as molecules removed over time the plasma concentration decreases
o Catalytic rate then also decreases in this exponential fashion (Linear Kinetics)
20 million molecules/second
40 million molecules/second
Linear Elimination Kinetics:
What happens when Elimination Processes become Saturated?
- When processes are saturated they become rate limited
- They cannot go any faster said to be saturated
- Parallels with
o Computer processing speed
o Car engine
o Eating pies, doughnuts or chewing a toffee
• When this happens the Elimination kinetics are referred to as Saturated or Zero Order
What is this graph showing?

Drug Elimination: Saturation or Zero Order Kinetics

What is this graph showing?

Saturated Zero Order Drug Elimination
Most drugs exhibit zero order kinetics at higher doses
- NOTE : Y axis is Rate of Elimination
- As [drug] increases Rate of elimination Levels off
- Reaches limit of capacity –cannot chew toffees any faster !
- This has important clinical implications !
Clinical Importance: Zero Order Kinetics
- Drugs at or near therapeutic dose with saturation kinetics
- More likely to result in ADRs/Toxicity
- Fixed rate of elimination per unit time
- Relatively small dose changes can
- Produce large increments in plasma [drug]
- Lead to serious toxicity
- Half life is not calculable cannot easily predict dosage regimes
- ‘Narrowing ‘ therapeutic window
- Greater risk of drug-drug interactions due to taking up sites
Clinical Importance: Zero Order Kinetics
Drug Monitoring Patient Groups
- Relatively few drugs in adults with Zero Order Kinetics at therapeutic dose
- Problem in elderly /infants with decreased/immature capacity
- Polypharmacy - competing at same processes
- Similarly problem in seriously ill – cancer liver disease alcoholic
- Reduced hepatic renal capacity easier to saturate
- Example drugs: Phenytoin; Prozac; Alcohol; MDMA
- Paracetamol at high dose (>20 tablets) saturate Phase I & II – can be fatal
Clinical Importance: Zero Order Kinetics
Drug Monitoring Patient Groups
- Relatively few drugs in adults with Zero Order Kinetics at therapeutic dose
- Problem in elderly /infants with decreased/immature capacity
- Polypharmacy - competing at same processes
- Similarly problem in seriously ill – cancer liver disease alcoholic
- Reduced hepatic renal capacity easier to saturate
- Example drugs: Phenytoin; Prozac; Alcohol; MDMA
- Paracetamol at high dose